The Partnership for Safe Medicines today released a new report that found suspicious, unauthorized, and illegal ingredients for popular diabetes and obesity injectables (commonly known as weight loss ...

The big game didn't live up to the big billing, but there was plenty to take in during commercial breaks and halftime.

Investors could be overestimating the contribution of Hims & Hers' compounded GLP-1 medications to its top line. Read why I ...

One developer of a weight loss medication, clinical-stage biotech Structure Therapeutics ( GPCR 0.16%), was a victim of a ...

Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.

Novo Nordisk called out suppliers of compounded weight loss drugs following Hims & Hers’ controversial Super Bowl ad.

As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...

More and more Americans are turning to GLP-1 injections to lose weight. FOX 7 Austin's Rebecca Thomas spoke to an Austin physician to discuss.

The “Check Before You Inject” ad goes on to note that some vials of compounded semaglutide “have been found to contain ...

The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

On Super Bowl Sunday, many tuning into the big game saw a controversial ad from the telehealth company Hims & Hers. The ...